Jessica M Faupel-Badger

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer
    Jessica M Faupel-Badger
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892 4254, USA
    Cancer Epidemiol Biomarkers Prev 15:1153-8. 2006
  2. pmc Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, National Cancer Institute, 9609 Medical Center Drive, 2W 172, Bethesda, MD, 20892, USA
    Horm Cancer 5:42-50. 2014
  3. pmc Evaluating postgraduate public health and biomedical training program outcomes: : lost opportunities and renewed interest
    Jessica Faupel-Badger
    National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    J Cancer Educ 28:18-26. 2013
  4. pmc Cluster analysis of placental inflammatory proteins can distinguish preeclampsia from preterm labor and premature membrane rupture in singleton deliveries less than 28 weeks of gestation
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, National Cancer Institute, Bethesda, MD 20892 7105, USA
    Am J Reprod Immunol 66:488-94. 2011
  5. pmc Maternal and cord steroid sex hormones, angiogenic factors, and insulin-like growth factor axis in African-American preeclamptic and uncomplicated pregnancies
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, Center for Cancer Training, National Cancer Institute, Bethesda, MD 20892 7105, USA
    Cancer Causes Control 23:779-84. 2012
  6. pmc Associations of pregnancy characteristics with maternal and cord steroid hormones, angiogenic factors, and insulin-like growth factor axis
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, Center for Cancer Training, National Cancer Institute, 6120 Executive Blvd EPS, Bethesda, MD 20892 7105, USA
    Cancer Causes Control 22:1587-95. 2011
  7. pmc Expanding cancer prevention education to national and international audiences: the National Cancer Institute's Principles and Practice of Cancer Prevention and Control annual summer course
    Jessica M Faupel-Badger
    National Cancer Institute, Cancer Prevention Fellowship Program, Bethesda, MD 20892 7105, USA
    J Cancer Educ 26:619-25. 2011
  8. pmc Maternal angiogenic profile in pregnancies that remain normotensive
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, Center for Cancer Training, National Cancer Institute, Rockville, MD USA
    Eur J Obstet Gynecol Reprod Biol 158:189-93. 2011
  9. pmc Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland
    J M Faupel-Badger
    Cancer Prevention Fellowship Program, Center for Cancer Training, National Cancer Institute, 6120 Executive Blvd EPS, Suite 150E, MSC 7105, Bethesda, MD 20892, USA
    Br J Cancer 103:1097-102. 2010
  10. pmc Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, Center for Cancer Training, National Cancer Institute, Bethesda, MD 20892 7105, USA
    Cancer Epidemiol Biomarkers Prev 19:292-300. 2010

Detail Information

Publications32

  1. ncbi request reprint Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer
    Jessica M Faupel-Badger
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892 4254, USA
    Cancer Epidemiol Biomarkers Prev 15:1153-8. 2006
    ....
  2. pmc Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, National Cancer Institute, 9609 Medical Center Drive, 2W 172, Bethesda, MD, 20892, USA
    Horm Cancer 5:42-50. 2014
    ..These data provide new avenues from which to explore the associations of the prolactin/prolactin receptor signaling network with breast tumorigenesis. ..
  3. pmc Evaluating postgraduate public health and biomedical training program outcomes: : lost opportunities and renewed interest
    Jessica Faupel-Badger
    National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    J Cancer Educ 28:18-26. 2013
    ..Suggestions for increasing interest in conducting and reporting evaluation studies of these structured postgraduate training programs are provided...
  4. pmc Cluster analysis of placental inflammatory proteins can distinguish preeclampsia from preterm labor and premature membrane rupture in singleton deliveries less than 28 weeks of gestation
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, National Cancer Institute, Bethesda, MD 20892 7105, USA
    Am J Reprod Immunol 66:488-94. 2011
    ..The risks of complications are different between iatrogenic (e.g. PE) and spontaneous (e.g. PL and membrane rupture) causes of preterm delivery, suggesting different underlying biology contributes to these placental conditions...
  5. pmc Maternal and cord steroid sex hormones, angiogenic factors, and insulin-like growth factor axis in African-American preeclamptic and uncomplicated pregnancies
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, Center for Cancer Training, National Cancer Institute, Bethesda, MD 20892 7105, USA
    Cancer Causes Control 23:779-84. 2012
    ..This study sought to compare an extensive profile of biological markers in both maternal and umbilical cord samples in preeclamptic and uncomplicated pregnancies of a predominantly African-American population...
  6. pmc Associations of pregnancy characteristics with maternal and cord steroid hormones, angiogenic factors, and insulin-like growth factor axis
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, Center for Cancer Training, National Cancer Institute, 6120 Executive Blvd EPS, Bethesda, MD 20892 7105, USA
    Cancer Causes Control 22:1587-95. 2011
    ....
  7. pmc Expanding cancer prevention education to national and international audiences: the National Cancer Institute's Principles and Practice of Cancer Prevention and Control annual summer course
    Jessica M Faupel-Badger
    National Cancer Institute, Cancer Prevention Fellowship Program, Bethesda, MD 20892 7105, USA
    J Cancer Educ 26:619-25. 2011
    ....
  8. pmc Maternal angiogenic profile in pregnancies that remain normotensive
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, Center for Cancer Training, National Cancer Institute, Rockville, MD USA
    Eur J Obstet Gynecol Reprod Biol 158:189-93. 2011
    ..We sought to determine if maternal characteristics are associated with angiogenic profile in the first and second trimester of normotensive pregnancies...
  9. pmc Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland
    J M Faupel-Badger
    Cancer Prevention Fellowship Program, Center for Cancer Training, National Cancer Institute, 6120 Executive Blvd EPS, Suite 150E, MSC 7105, Bethesda, MD 20892, USA
    Br J Cancer 103:1097-102. 2010
    ....
  10. pmc Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, Center for Cancer Training, National Cancer Institute, Bethesda, MD 20892 7105, USA
    Cancer Epidemiol Biomarkers Prev 19:292-300. 2010
    ..2% and < or =17.8%). Comparison with the LC-MS/MS method suggests that the widely used RIA and ELISA estrogen metabolite measures may be problematic, especially at low estrogen metabolite levels characteristic of postmenopausal women...
  11. pmc Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethnicity and gender
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Ann Epidemiol 19:841-9. 2009
    ..S. population-based study where these associations could also be stratified by race/ethnicity and gender...
  12. pmc Pregnancy weight gain is not associated with maternal or mixed umbilical cord estrogen and androgen concentrations
    Jessica M Faupel-Badger
    Division of Cancer Prevention and Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7105, USA
    Cancer Causes Control 20:263-7. 2009
    ..Our results are not consistent with an effect of pregnancy weight gain being mediated by this pathway as reflected by hormone concentrations at the end of pregnancy...
  13. ncbi request reprint Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, Division of Cancer Prevention and Mammary Biology and Tumorigenesis Laboratory, National Cancer Institute, 37 Convent Drive, Building 37, Room 1106, Bethesda, MD 20892 4254, USA
    Cancer Epidemiol Biomarkers Prev 16:2784-6. 2007
  14. ncbi request reprint Association of IL-10 polymorphisms with prostate cancer risk and grade of disease
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program, Division of Cancer Prevention and Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892 4254, USA
    Cancer Causes Control 19:119-24. 2008
    ..56, 95% CI 1.26-5.20 for -819). These data demonstrate genotypes correlated with low IL-10 production are associated with increased risk of prostate cancer and with high-grade disease in this population...
  15. ncbi request reprint Plasma volume expansion in pregnancy: implications for biomarkers in population studies
    Jessica M Faupel-Badger
    Mammary Biology and Tumorigenesis Laboratory, Center for Cancer Research, National Cancer Institute, MSC 4254, 37 Convent Drive, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 16:1720-3. 2007
    ..We present PVE as a topic for consideration in population-based studies, examples of the types of studies where PVE may be relevant, and our own analysis of one such study in the text below...
  16. ncbi request reprint Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer
    Jennifer Eng-Wong
    Division of Cancer Prevention and Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 1906, USA
    Cancer Epidemiol Biomarkers Prev 12:1468-73. 2003
    ..Increases in IGFBP-3 may potentially decrease the activity of circulating IGF-I. The effect of modulating the IGF pathway and leptin on breast cancer risk needs additional evaluation...
  17. pmc Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland
    Sarah J Nyante
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Rockville, MD 20852, USA
    Breast Cancer Res 13:R42. 2011
    ..Thus, we examined the relationship between single nucleotide polymorphisms (SNPs) in PRL and PRLR, serum prolactin levels and breast cancer risk in a population-based case-control study...
  18. ncbi request reprint A pilot study of dose intense doxorubicin and cyclophosphamide followed by infusional paclitaxel in high-risk primary breast cancer
    Jo Anne Zujewski
    National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Breast Cancer Res Treat 81:41-51. 2003
    ..Administration of dose dense AC followed by infusional paclitaxel in 14-day cycles is feasible and this regimen is active in breast cancer...
  19. pmc Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer
    Jennifer Eng-Wong
    Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    Cancer Epidemiol Biomarkers Prev 17:1696-701. 2008
    ..We evaluated the effect of raloxifene on mammographic density and MRIV in premenopausal women at increased risk for breast cancer...
  20. pmc Association of serum sex steroid hormone hemodilution and body mass index among healthy postmenopausal women
    Hannah P Yang
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Ann Epidemiol 21:466-71. 2011
    ..Assessing the relationship of hormone concentration to total mass varies by body mass index (BMI) is etiologically important because obesity is related to hormone metabolism and cancer risk...
  21. pmc Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer
    Gretchen L Gierach
    Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Office of Preventive Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Breast Cancer Res Treat 123:245-55. 2010
    ..Taking these factors into account did not significantly alter the results of the age/body mass index-adjusted analysis. Our results do not provide support for an independent effect of BRCA1/2 mutation status on mammographic density...
  22. ncbi request reprint A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer
    Peter F Lebowitz
    Medical Oncology Clinical Research Unit, National Cancer Institute NIH, 9000 Rockville Pike, Bethesda, MD 20892, USA
    Clin Cancer Res 11:1247-52. 2005
    ..We studied the safety and toxicity of tipifarnib in combination with tamoxifen in metastatic breast cancer. The pharmacokinetics and pharmacodynamics of tipifarnib were also assessed...
  23. pmc Outcome evaluation of the National Cancer Institute career development awards program
    Julie L Mason
    National Cancer Institute, Rockville, MD, USA
    J Cancer Educ 28:9-17. 2013
    ..The NCI K program had a positive impact, not only on participants' biomedical research careers but also on achieving outcomes significant to the scientific enterprise...
  24. ncbi request reprint Gynecologic and hormonal effects of raloxifene in premenopausal women
    Ahalya Premkumar
    Department of Diagnostic Radiology, Warren G Magnuson Clinical Center, Bethesda, Maryland, USA
    Fertil Steril 88:1637-44. 2007
    ..To assess the effects of raloxifene on the ovaries, uterus, and serum hormone levels in premenopausal women...
  25. ncbi request reprint Raloxifene and its role in breast cancer prevention
    Jennifer Eng-Wong
    National Cancer Institute, Medical Oncology Clinical Research Unit, Bldg 10, Rm 12N226, Bethesda, MD 20892, USA
    Expert Rev Anticancer Ther 4:523-32. 2004
    ..The utility of raloxifene will depend on the outcome of trials that are now underway, as well as acceptance by high-risk women and their healthcare practitioners...
  26. doi request reprint Preparation of human serum for prolactin measurement by multiple reaction monitoring mass spectrometry
    Timothy J Waybright
    Frederick National Laboratory for Cancer Research, Frederick, MD, USA
    Methods Mol Biol 1002:195-203. 2013
    ....
  27. pmc Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop
    Jessica M Faupel-Badger
    Cancer Prevention Fellowship Program and Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
    J Natl Cancer Inst 105:166-74. 2013
    ..This report summarizes conclusions of the workshop, proposes avenues for future research on the PLC and its relationship with breast cancer risk, and identifies opportunities to translate this knowledge to improve breast cancer outcomes...
  28. ncbi request reprint Sentinel lymph node biopsy in the management of ductal carcinoma in situ
    JoAnne Zujewski
    National Cancer Institute, Bethesda, MD 20892, USA
    Clin Breast Cancer 6:216-22. 2005
    ..Sentinel lymph node biopsy in DCIS is associated with known risks, and health care benefits, if any, have not been demonstrated. Sentinel lymph node biopsy is not recommended in patients with DCIS...
  29. ncbi request reprint Current NCI-sponsored Cooperative Group trials of endocrine therapies in breast cancer
    Jennifer Eng-Wong
    Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA
    Cancer 112:723-9. 2008
    ..Close research partnerships that promote large-scale translational research are essential to the continuation of rapid achievements in this field...
  30. pmc Health disparities around the world: perspectives from the 2012 Principles and Practice of Cancer Prevention and Control course at the National Cancer Institute
    Neetu Chawla
    National Cancer Institute, Bethesda, MD University of Utah and Huntsman Cancer Institute, Salt Lake City, UT
    J Oncol Pract 9:e284-9. 2013
    ..Themes related to the challenges health disparities present to cancer prevention efforts and potential solutions to these issues emerged from facilitated group discussions among the 2012 course participants...
  31. ncbi request reprint A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer
    Peter F Lebowitz
    Medical Oncology Clinical Research Unit, Cancer Therapeutics Branch, Laboratory of Pathology, Biostatistics and Data Management, and Surgery Branch, National Cancer Institute, Bethesda, Maryland 20892, USA
    Clin Cancer Res 10:6764-9. 2004
    ..This study evaluated the toxicity and efficacy of docetaxel/capecitabine as neoadjuvant treatment for stage 2/3 breast cancer...
  32. ncbi request reprint Effect of raloxifene on salivary sex steroid concentrations in premenopausal women
    Robert T Chatterton
    Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA
    J Endocrinol 191:599-604. 2006
    ..The results reflect increases in serum oestradiol reported earlier...